Profile
Paula Treutiger is a former Director at CellaVision AB, former Director-Corporate Communication & IR at Medicover AB, former Portfolio Manager at Swedbank Robur Fonder AB, former Vice President-Corporate Communications at Gambro AB, former Head-Communications, IR & Sustainability Media at Meda AB, former Analyst at ABN AMRO SE, former Head-Communication & Investor Relations at Swedish Orphan Biovitrum AB, and former Head-Communication & Investor Relations at Senzime AB. She obtained her undergraduate degree from the University of Stockholm.
Former positions of Paula Treutiger
| Companies | Position | End |
|---|---|---|
| SENZIME AB | Investor Relations Contact | 2023-07-31 |
| SWEDISH ORPHAN BIOVITRUM AB | Investor Relations Contact | - |
Swedbank Robur Fonder AB
Swedbank Robur Fonder AB Investment ManagersFinance Swedbank Robur aims to create sustainable, long-term return for their investors, while also contributing to the development of society and the environment. All their funds have a strict sustainability overlay where all managers use the firm’s proprietary ESG platform, RobuS, which uses both external and internal analysis to share and evaluate sustainability data. The firm actively selects companies based on fundamental and quantitative analysis. | Portfolio Manager-Equities | 2011-06-01 |
ABN AMRO SE
ABN AMRO SE Investment Banks/BrokersFinance Provides security brokerage services | Analyst-Equity | 2005-03-10 |
| MEDICOVER AB | Investor Relations Contact | - |
Training of Paula Treutiger
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
Senzime AB
Senzime AB Medical SpecialtiesHealth Technology Develops and markets an enzyme based biosensor technology | Health Technology |
Swedbank Robur Fonder AB
Swedbank Robur Fonder AB Investment ManagersFinance Swedbank Robur aims to create sustainable, long-term return for their investors, while also contributing to the development of society and the environment. All their funds have a strict sustainability overlay where all managers use the firm’s proprietary ESG platform, RobuS, which uses both external and internal analysis to share and evaluate sustainability data. The firm actively selects companies based on fundamental and quantitative analysis. | Finance |
Gambro AB
Gambro AB Medical SpecialtiesHealth Technology Develops and manufactures dialysis equipment and blood purification products | Health Technology |
Meda AB
Meda AB Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
CellaVision AB
CellaVision AB Medical SpecialtiesHealth Technology Manufactures medical instruments | Health Technology |
University of Stockholm
University of Stockholm Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ABN AMRO SE
ABN AMRO SE Investment Banks/BrokersFinance Provides security brokerage services | Finance |
Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceuticals and orphan drugs in the areas of hematology, immunology and specialty care | Health Technology |
Medicover AB
Medicover AB Medical/Nursing ServicesHealth Services Provides health care and diagnostic services | Health Services |
- Stock Market
- Insiders
- Paula Treutiger
















